Germany vs Netherlands: Share of e coli bloodstream infections due to antimicrobial resistant
Germany
9.41
in 2022
Netherlands
7.61
in 2022
Germany rank
40th
Netherlands rank
43rd
Share of e coli bloodstream infections due to antimicrobial resistant over time
- Germany
- Netherlands
How they compare
Germany currently reports 9.41 against 7.61 in Netherlands, a difference of 1.8.
That makes Germany's figure about 1.2 times Netherlands's.
Across all 6 years both countries report, Germany has been ahead every year.
Germany ranks 40th and Netherlands ranks 43rd of 46 countries.
Germany has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Germany | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 11.97 | 6.89 | 5.08 | Germany |
| 2020s | 9.52 | 6.95 | 2.57 | Germany |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e coli bloodstream infections due to antimicrobial resistant, Germany or Netherlands?
- Germany, at 9.41 against 7.61 in Netherlands as of 2022.
- What is the difference in share of e coli bloodstream infections due to antimicrobial resistant between Germany and Netherlands?
- 1.8, with Germany ahead.
- How many years of comparable data are there for Germany and Netherlands?
- 6 years are reported by both, from 2017 to 2022.
- How do Germany and Netherlands rank globally for share of e coli bloodstream infections due to antimicrobial resistant?
- Germany ranks 40th and Netherlands ranks 43rd of 46 countries.
- Where does this data come from?
- Our World in Data, published as Share of e coli bloodstream infections due to antimicrobial resistant bacteria. Statizoid refreshes it automatically from the source and publishes the full history for both places.